Skip to content

Case-control study, 2023

Do women with PMDD show different brain responses to emotions across the menstrual cycle?

Women with PMDD show increased activity in emotion-processing brain areas during the late luteal phase compared to controls, and this activity is linked to the balance of allopregnanolone and isoallopregnanolone in different ways than in healthy women.

Early or limited evidence Women with PMDD and asymptomatic controls (exact sample size not stated)

What they did

Women with PMDD and asymptomatic controls underwent brain scans (fMRI) during the mid-follicular and late-luteal phases while viewing emotional images. Researchers measured brain activity in emotion-processing regions and blood levels of progesterone-derived neurosteroids.

What they found

Women with PMDD showed greater activity in brain regions involved in emotion processing, particularly the parahippocampal gyrus and amygdala, during the late-luteal phase. Activity in these regions was positively associated with the ISO/ALLO ratio in PMDD subjects but negatively associated in controls.

What it means for you

Women with PMDD may have brains that react too strongly to emotional information during the luteal phase in ways linked to abnormal sensitivity to normal hormone changes. This helps explain why mood symptoms worsen at that time, though we do not yet know if treating hormones would help.

2

cycle phases tested (mid-follicular and late-luteal)

2

neurosteroids measured (allopregnanolone and isoallopregnanolone)

About the study

Original title
Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids
Authors
Stiernman L, Dubol M, Comasco E et al.
Journal
Translational psychiatry
Year
2023
Study design
Case-control study
What was tested
None
Open access
Yes
Original abstract

Premenstrual dysphoric disorder (PMDD) is a debilitating disorder characterized by severe mood symptoms in the luteal phase of the menstrual cycle. PMDD symptoms are hypothesized to be linked to an altered sensitivity to normal luteal phase levels of allopregnanolone (ALLO), a GABA A -modulating progesterone metabolite. Moreover, the endogenous 3β-epimer of ALLO, isoallopregnanolone (ISO), has been shown to alleviate PMDD symptoms through its selective and dose-dependent antagonism of the ALLO effect. There is preliminary evidence showing altered recruitment of brain regions during emotion processing in PMDD, but whether this is associated to serum levels of ALLO, ISO or their relative concentration is unknown. In the present study, subjects with PMDD and asymptomatic controls underwent functional magnetic resonance imaging (fMRI) in the mid-follicular and the late-luteal phase of the menstrual cycle. Brain responses to emotional stimuli were investigated and related to serum levels of ovarian steroids, the neurosteroids ALLO, ISO, and their ratio ISO/ALLO. Participants with PMDD exhibited greater activity in brain regions which are part of emotion-processing networks during the late-luteal phase of the menstrual cycle. Furthermore, activity in key regions of emotion processing networks - the parahippocampal gyrus and amygdala - was differentially associated to the ratio of ISO/ALLO levels in PMDD subjects and controls. Specifically, a positive relationship between ISO/ALLO levels and brain activity was found in PMDD subjects, while the opposite was observed in controls. In conclusion, individuals with PMDD show altered emotion-induced brain responses in the late-luteal phase of the menstrual cycle which may be related to an abnormal response to physiological levels of GABA A -active neurosteroids.

Reproduced under CC-BY.

Topics